Celcuity, Inc. (CELC) vs Enliven Therapeutics, Inc. (ELVN)
- Celcuity, Inc. CELC 56.16 −6.87%
- Enliven Therapeutics, Inc. ELVN 37.32 −5.11%
Celcuity, Inc. and Enliven Therapeutics, Inc. are both Biotechnology companies. Celcuity, Inc. and Enliven Therapeutics, Inc. are of similar size ($3.0B and $2.9B). Across the 8 metrics below, Enliven Therapeutics, Inc. leads on 6 and Celcuity, Inc. on 2.
Valuation
Profitability
| Metric | CELC | ELVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,433.70%) | (15.31%) | (56.36%) |
| Return on assets | (44.77%) | (14.98%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack